Dr François Martelet joined NetScientific in 2015, bringing over 20 years of biopharma experience and a track record of shaping and developing businesses to deliver returns. He has broad experience in both large and small companies, deep knowledge of commercialisation and proven managerial capabilities. Previously, François served as senior advisor to the CEO and Interim SVP at Stallergenes SA, responsible for international commercial strategies. His previous roles include CEO of Topotarget A/S, a European biotech company specialising in oncology therapeutics, which he transformed from a research based organisation into a late-stage clinical development company ready for a European exit, and CEO of Avax Technologies Inc., a US biotech company specialised in therapeutic oncology vaccines. He also held senior commercial positions at Merck & Co, Inc., Novartis Pharma, Schering-Plough and Eli Lilly. François gained a Doctorate in Medicine and a Master’s Degree in Business from Dijon University, and holds a Degree in Legal Medicine from R. Descartes University School of Medicine, Paris. He is also a graduate of the Advanced General Management Program at INSEAD. François Martelet’s awards include the Pasteur Institute medal (1989) and the Knight of the French National Order Merit (2011).